A global leader in the development, manufacture and commercialisation of diagnostic technologies for the sleep, brain and ultrasonic blood-flow monitoring applications.
Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany-based DWL Elektronishe Systeme GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.
Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovator by both German and Australian Governments.
Our Vision is to set the innovative and technological standards in monitoring products for improved health care. We exist to identify and deliver accessible medical technologies to the world. We provide our customers with products of superior technology, ease of use and reliable quality.
People: Trust, Respect and Relationships
Ethics: Uncompromising integrity in business conduct
Contribution: to the industry and community
Compumedics is a leading global, innovative developer and manufacturer of medical devices for:
Compumedics is the technological leader in its chosen markets: